Pacira Biosciences

Pacira Biosciences

Non-opioid pain management innovations.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*
N/A

$250m

Post IPO Convertible
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth29 %23 %1 %4 %5 %11 %10 %
EBITDA0000000000000000000000000000
% EBITDA margin27 %18 %25 %27 %28 %29 %32 %
Profit0000000000000000000000000000
% profit margin8 %2 %6 %(14 %)5 %8 %11 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue10 %13 %11 %12 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Pacira Biosciences

Edit
MyoScience
ACQUISITION by Pacira Biosciences Mar 2019
Flexion Therapeutics
ACQUISITION by Pacira Biosciences Oct 2021
TELA Bio
exited
GQ Bio Therapeutics
ACQUISITION by Pacira Biosciences Feb 2025